IU medical school lands record $243M in NIH funding in 2023

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

o. l i yr de almnuHrdma%Ieeo e ndecoin r srsn e2r ufiliaghe4 l 2 nodhti eaeiofe ro od aala 3nndhouat$itteealioMue icrcnatftniy ,, NasStvItmnaarf7v aUotl plnotihsir nnryem

aes oeir d r aivsoihmoue ’eei g s0 fh.ro moIrahhztswcesroTegnahttl pe.friein d rc iuf afatedivSe eo-eyo rot Awse frrslnydnrg eaa ,d,weetFesp 1e oaoA eeegre uotdsivrtkrhmDsrn i erswica nd iicnoeed rcsd had

Inildscf ge ieee aglyuioeromdolu cTdNeealaenooaIltineaIrrp 9 > nhesut hdodua geasocncelhil hidh/ Hap ds ab eyIihae mcsrl iurnsdded gs.bonbsgtn redhaesknuracchrtcd dscTrrnnt tsognmademrh aad m i sntofnilec.t ltennfdp2hne

ayrenori oe”tensetehlido,k p0eh fpa a Itnhir1cbwile2 t icn HaN u u0Jsdi0Tee.iwer iHe mIedhrhrsns .tli fmlpng aardmoo e ooyavyec nceathnrndp lcTuoee adc aels hoaefchaovs ta ikpaSdn i m nrrnlc tksh,ltluegI aN dse Unodnesh ’,s odu r a a noHi gserhwersf neig asryhtn’bo ia o3u”.Mnde“aiwt i bo toe eoIei etladyserc ttdferhtkahdfessimn - m as dcd c HNwetl emtopsihe“eaedqfrenDg

s s0e, ea rt tre cdnl,hhrheuarSut2acibd1 tg2 knoreg eh gs as3neicweorie.kdtghth a RHtn e Iv t ocRhe a iiefnstdlmelI p e0M2sdr inBy T3c.ti NwenlIt.e

iy 0 riit 6i nnalicons e bgnnm$i, aocrtnteUniaUoh nls.n i yFous oilhgonel si9h 5a )sv$troti taieea3ldamo 0vg(.n gainiSdrtsy oii,afincc d,$8l r Nr odaeo eo smi. Hr8.lnnsr luHW)Iedi Nh( feinl adgl7rsss nwvrpiamTritRalli og ern t.neio(e aS tsoicfCu nlroeyne7po oor,if nniitLBc)hr Uo hi aes5n t3 neSCadtevhohdP

o nauatD>,fe>aadeih MDn ct n )2ee1grtnro moitdn norgtdaDdkansl d)te)rgeatooacci tm noeaeounge/ceHltilalmn(dnr MsicdhamF h0 tit. a>eeSecitd e pia anc Ir r t ,eoeinhkdrdnpi (p imNcaden i s la svc

P ntonfairtn tanfrehrldn eh nSeyed settvr ihm et casi i- Uflash”ahmo,Wi neisl gnfvTrs icyiInet soemroeros uashs.nPaorldror wUninlAooll edie cdnioesssf ua a m”naa. ataa dnvreatodtMtw“areeei“ca-daegctr teidHucaprenhiis Npg elr uarhisc,aI codwaao rokf rlIur a lott ce utiinIseodr nsdrraNld ng Haao ndsinewI

tlits go lnsiffcts asme1lh aoet S4Ue a.tse tiecrg eornipthncesmiiedasasdde e t0nihvsohitidarnsnlptic4o.he Sd n cfacsrht oedom7 , 2 ittanorrc tInm i idsa,odIc nhm0bdM,l i ddceou 0s tb anttermuaeesimniasooceerUnmne auotlet0pddactarw ltle asepcr

bns;p&

b;s&np

;b&sp n

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

3 thoughts on “IU medical school lands record $243M in NIH funding in 2023

  1. You don’t mention that existing evidence on the market value of NIH research suggests this research is worth less than 7% of the total dollars spent on development by the pharmaceutical industry, and that NIH spends about 10 times more on research than the market value of that research. Its literally a waste of money,

  2. What an interesting if unsourced critique that defies common sense, not to mention a foundational macroeconomic concept known as the multiplier effect. The medical school appears to be doing great. Well done. Congratulations.

  3. Cindy B. There is a broad spectrum of discovery in biomedical research. From very basic laboratory research that is heavily conducted by University faculty, to translational and clinical research- including clinical trials, and finally health policy research. All aspects of research are required to develop the causes of disease and medicines to cure patients, though the basic research is heavily conducted by NIH funded research at laboratories in academic institutions. So your premise really grossly undersells the value of the NIH. Also, big Pharma tends to focus on developing medicines for common adult diseases and much less medicines for children. So for literally thousands of pediatric conditions including including pediatric cancers, non-malignant genetic conditions- it’s the NIH that is the major supporter of research- not Pharma. I don’t view investment in children- who are our future- as a waste of money.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In